ABG
Asbury Automotive Group, Inc.
ABG's fundamentals are mixed: it turned 4.4% of its revenue into free cash flow, but its operating margin fell 1 points to 4.2%. At 8.0x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ABG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Under pressure |
ABG's revenue, profitability and cash flow are currently stable, but its balance sheet is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ABG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $132 | -34% |
| Forward | 7.5x | $200 | — |
| Current | 8x | $200 | — |
| Fair | 8.1x | $204 | +2.3% |
| Expensive | 12x | $300 | +50% |
Historical ranges are pointers, not guarantees.
ABG's PE is in its fair range at 8.0x. If earnings grow as analysts expect, today's price would be 7.5x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ABG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect ABG's earnings to grow, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ABG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $26.59 | +5.9% |
| Q3 2026 | $25.10 | -12% |
| Q2 2026 | $26.78 | -2.2% |
| Q1 2026 | $28.29 | +35% |
| Q4 2025 | $25.13 | +17% |
| Q3 2025 | $28.52 | +60% |
| Q2 2025 | $27.37 | +39% |
| Q1 2025 | $21.00 | -24% |
| Q4 2024 | $21.50 | -25% |
ABG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ABG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.4B | -8.1% |
| Q2 2026 | $4.4B | +0.3% |
| Q1 2026 | $4.1B | -0.9% |
| Q4 2025 | $4.7B | +3.8% |
| Q3 2025 | $4.8B | +13% |
| Q2 2025 | $4.4B | +3% |
| Q1 2025 | $4.1B | -1.3% |
| Q4 2024 | $4.5B | +18% |
ABG's revenue grew through 2024 and has held roughly level since: $4.4B last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.7% | -0.4 points |
| Q2 2026 | 5% | -0.9 points |
| Q1 2026 | 4.7% | -0.9 points |
| Q4 2025 | 2.7% | -2.6 points |
| Q3 2025 | 5% | -0.4 points |
| Q2 2025 | 5.9% | +3.5 points |
| Q1 2025 | 5.7% | -0.6 points |
| Q4 2024 | 5.3% | +2.1 points |
ABG has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ABG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ABG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $265.1M | -14% |
| Q2 2026 | $129.4M | +42% |
| Q1 2026 | $223.2M | -0.8% |
| Q4 2025 | $151.9M | -38% |
| Q3 2025 | $306.9M | -24% |
| Q2 2025 | $91.4M | +$245.8M |
| Q1 2025 | $225M | +27% |
| Q3 2024 | $404.3M | +2134% |
ABG has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ABG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -300K shares |
| 1 year | -8.2% | -1.6M shares |
| 3 years | -13% | -2.7M shares |
| 5 years | -7.7% | -1.5M shares |
| Available history | -6.7% | -1.3M shares |
ABG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $130.6M |
| Q1 2026 | $147M |
| Q4 2025 | $37.2M |
| Q3 2025 | $37.3M |
| Q2 2025 | $200,000 |
| Q1 2025 | $12.5M |
| Q4 2024 | $100,000 |
ABG spent $315M buying back its own shares over the past year, about six times what it spent the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ABG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.4x | Elevated |
ABG's net debt is about 3.9 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ABG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 52.0 | Neutral |
ABG's weekly RSI is 50 (neutral) and its Stochastic is 52 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ABG PE vs Consumer Cyclical Sector
| Metric | ABG | Sector median | Relative |
|---|---|---|---|
| PE | 8x | 18x | 56% below |
| PE % | 46 | 47 | 1 pt below |
ABG is trading at 8.0x earnings, a 56% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ABG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.0 | 8.5% above |
| 20 week MA | $201.3 | 0.9% below |
| 50 week MA | $208.8 | 4.4% below |
| 100 week MA | $225.2 | 11% below |
| 200 week MA | $224.5 | 11% below |
ABG has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ABG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $113.6 | $139.8 | +23% |
| 2021 | $139.8 | $164.4 | +18% |
| 2022 | $164.4 | $169.0 | +2.8% |
| 2023 | $169.0 | $225.0 | +33% |
| 2024 | $225.0 | $244.5 | +8.7% |
| 2025 | $244.5 | $241.5 | -1.3% |
| 2026 YTD | $241.5 | $199.6 | -17% |
ABG has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.